The European Association of Neuro-Oncology honours outstanding research with four EANO Congress Awards. The winning abstracts were presented at the EANO Meeting 2021 taking place virtually from September 25-26, 2021. Click here to view the programme. Congratulations to all recipients!

Best Oral Presentation Award for Clinical research (kindly supported by Vienna Medical Academy)

Florence Laigle-Donadey, Hôpital Pitié-Salpêtrière, Paris, France

Surgery for glioblastomas in the elderly: an ANOCEF trial (CSA)

Best Oral presentation Award for Basic research

Emre Kocakavuk, The Jackson Laboratory for Genomic Medicine, Farmington, CT, United States

Radiotherapy is associated with a deletion signature that contributes to poor outcomes in glioma patients

Best Oral presentation Award for Translational research

Lena Hänsch, Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Development and characterization of CD317-specific CAR T cells as an innovative immunotherapeutic strategy against glioblastoma

Best Oral Presentation Award for Supportive care and quality of life research

Marijke Coomans, Leiden University Medical Center, Leiden, Netherlands

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period

EANO Young Investigator Scholarship 2021

Alberto Picca, Paris, France

Chromosome 1p19q codeletion frequency, but not survival, varies according to the IDH mutation subtypes: analysis of 1050 IDH-mutated diffuse gliomas.

Philipp Karschnia, Munich, Germany

The role of CX3CR1 on tumor-associated macrophages and microglia (TAM/M) for brain metastasis formation from lung cancer

Philipp Lohmann, Juelich, Germany

Radiomics for the non-invasive determination of the BRAF mutational status in patients with melanoma brain metastases

Conor Gillespie, Liverpool, United Kingdom

The Natural History of a Residual Intracranial Meningioma- Volumetric Growth and Predictors of Progression

Wies Vallentgoed, Rotterdam, The Netherlands

Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium

EANO Young Investigator Scholarship of Excellence

C. Tesileanu, Rotterdam, The Netherlands

MGMT promoter status in IDH1/2 mutant anaplastic astrocytoma patients assessed by DNA methylation profiling and qMS-PCR: a report from the EORTC Brain Tumor Group

EANO Nurses Scholarship 2021

Florien Boele, Leeds, United Kingdom

Health-related quality of life in low-grade glioma survivors 26 years after diagnosis

EANO Scholarships for the EANO Youngsters-CSNO Session

Maximilian Mair, Vienna, Austria

Adjuvant treatment versus initial observation in newly diagnosed WHO grade II and grade III oligodendroglioma: real-life data from two academic, tertiary care centers in Austria

Christina Flies, Utrecht, The Netherlands

Conventional MRI criteria differentiate true tumour progression from treatment-induced effects in irradiated WHO grade 3 and 4 gliomas

TECHNICAL INFORMATION

• For optimum results when using the Online Submission System, it is recommended that you use one of the following browsers: Google Chrome 33 or higher, Internet Explorer 8.0 or higher, Mozilla FireFox 16 or higher, Safari 5.0 or higher.
• Please note that in rare cases you may encounter an issue copy/pasting from Word for Mac, triggering an error message that your title cannot exceed 1,000 characters. In this case please reload the page and either type or copy/paste the title from a plain text application.
• JavaScripts and cookies need to be enabled in your browser. Instructions to enable cookies are given on the login page.

ACCOUNT MANAGEMENT - PERSONAL INFORMATION

• The creation of a user account is required for the submission of an abstract.
• Please create only one account per submitting author. The system stores your information. If you choose to submit more than one abstract you will not need to create another account. See „Returning users“.
• After you created the account, the system will display a password and username that will allow you to return and edit, delete or withdraw your abstract at a later stage.
• Personal information can be edited if necessary by clicking the „Profile“ icon (e.g. in case of an address change). Attention: All correspondence regarding the acceptance of your abstract will be emailed to the address given by you in the „author section“. Please provide a working email address.

First time users:

1. When entering the online submission portal, click on „Create new account“. Fill in all required fields and save your personal information by clicking “Save & Continue” in the online form.
2. Please remember to create a password not being used for other logins (i.e. bank accounts, market places etc.)
3. Once you have logged into the submission portal, you will be directed to the abstract submission site for EANO 2021. Click on the “+New” button to start with your abstract submission. If you cannot see this button, please make sure you are located in the tab labelled “submissions”.
4. When clicking the “+New” button a new tab will open in your browser. Follow step by step the instructions for submission.
5. At the end of the process, you will see a summary of your submission in the last step (“Review my work“), which you may print. Your abstract should now show as complete in the submission site.

Returning users, continuing an aborted submission or editing an abstract already submitted:

1. Login with the username (your email address) and password that you received when creating the account.
2. Locate the abstract and click on the displayed abstract title to make changes or complete the abstract.
3. Continue your submission or click on desired menu item you wish to change.
4. Changes can be made until the submission deadline.

Returning users, submitting another abstract:

1. Login with the username and password that you received when creating the account.
2. Click on the “+New” button to start with a new submission.
3. Carefully follow the step-by-step instructions.
   
   

CORRECTIONS / WITHDRAWAL OF ABSTRACTS

• You can edit or delete your abstract in the online submission system until the deadline of April 26^th, 2021.
• Titles of submitted abstracts are displayed in the Welcome Area, together with the information on whether the submission is complete or incomplete. To edit one of these abstracts, simply click on the title.
• The submission system stores the information in „real time“ in a database. The moment you reach the „Summary“ at the end of the submission process your abstract has been received. However you will still be able to come back and make modifications until the deadline.
• You may print the summary page for your records. The system also has an e-mail confirmation feature. Simply click the appropriate link on the summary page and fill in your email address(es) in the appropriate box.

Once you have looged into the submission portal with your account, click on the “+New” button to start with your abstract submission.

Read through the affirmations carefully and confirm them.

SUBMISSION STEP 1: TITLE

• In the title, please use capital letters ONLY where necessary (e.g. ‚Detection of two novel large mutations in SLC7A9 by semi-quantitative fluorescent multiplex PCR‘).
• Please DO NOT format the title in bold, underline, or enter line breaks. Use italics only where required by nomenclature.
• The title is limited to 25 words!

SUBMISSION STEP 2: AFFIRMATION / ALLOCATION / TYPE

1. Confirm the affirmation regarding the registration.

2. Please select whether the content of your abstract should be part of the EANO Main Meeting or patient related sessions (focus for nurses and AHPs).

EANO MAIN MEETING: Friday, September 24 - Sunday, September 26
Your abstract will be presented as a poster in the Poster Sessions, or as a talk during the Oral Sessions of the EANO Meeting.

Patient related (NURSE/AHP) SESSIONS: Thursday, September 23
Your abstract will be presented as a poster in the Poster Sessions, or as a talk during the sessions with patient related content of the EANO Meeting.

3. Please indicate whether your abstract is a regular, encore or trial in progress abstract. For an encore abstract please fill in where the abstract has been published before (journal name, issue, name of conference…) and provide a rationale for the resubmission.

4. Please indicate whether you would be willing to present your work virtually in case the meeting format requires a change to a virtual conference due to COVID-19 restrictions.

SUBMISSION STEP 3: TOPIC

Please take care to allocate your submission to a suitable topic. The respective topic needs to be selected from a list.
Please select only ONE topic that refers to the main subject of your abstract.

01.  Blood brain barrier/ Blood tumor barrier
02.  Radiobiology
03.  Cognition in brain tumors
04.  Tumor heterogeneity, plasticity and impact on therapeutic response
05.  Radiation technologies
06.  Pediatric brain tumors
07.  Multilayer intra- and postoperative diagnostics and novel imaging technologies
08.  Combined immunotherapies
09.  Imaging strategies to improve neurosurgical outcome
10.  Advanced brain tumor models
11.  QoL/QoD
12. Symptom management
13. Preclinical neuro-oncology
14. Clinical neuro-oncology
15. DNA damage repair and genomic instability
16. Brain tumor microenvironment

SUBMISSION STEP 4: KEYWORDS

• Please enter up to 3 keywords describing your work (required).

SUBMISSION STEP 5: AUTHORS

• No more than 10 authors can be listed.
• A maximum of 2 institutions per author is allowed.
• The order of the authors as well as the name of the presenting author (marked in green) can be edited during the submission process.

SUBMISSION STEP 6: ABSTRACT TEXT

The abstract body should be structured as follows:

-  Background
-  Material and Methods
-  Results
-  Conclusion

• The text cannot exceed 2500 characters without spaces (350-400 words), excluding title and authors (minimum 500 characters).
• The abstract must be submitted in good English.
• No tables, no graphics or illustrations are allowed.
• No literature must be cited.
• The text may be typed in or copy/pasted from an existing document.
• Special characters are widely supported.
• Support/Disclosure: Enter the source(s) of contributed support and/or grant numbers at the end of the abstract text section.

SUBMISSION STEP 7: PRESENTATION PREFERENCE

Please indicate your preference in this step, especially in case you do not want your abstract to be selected as oral presentation.

SUBMISSION STEP 8: YOUNG INVESTIGATOR TRAVEL

Please indicate if you want to apply for a Young Investigator Travel Scholarship and select the respective Scholarship.

SUBMISSION STEP 9: SUBMISSION SUMMARY

• The summary page will display all information related to your abstract.
• Please make sure you print the summary page for your records.
• The system also has an e-mail confirmation feature. Simply click the appropriate link on the summary page and fill in your email address(es) in the appropriate box.

If you choose to delete the submission, this can be made here. Please note that you will be able to retrieve deleted submissions.